Skip to main content
. 2019 Feb 13;16(2):394–403. doi: 10.1007/s13311-018-00708-x

Fig. 2.

Fig. 2

Changes from baseline in the cerebral metabolic rate of glucose consumption (CMRglc) in the parietal lobes and inferior frontal gyri (IFG) in the cilostazol and placebo groups. p values were obtained from paired t tests between pre- and postmedication conditions